|
1
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Patrawala L, Calhoun-Davis T,
Schneider-Broussard R and Tang DG: Hierarchical organization of
prostate cancer cells in xenograft tumors: The CD44+alpha2beta1+
cell population is enriched in tumor-initiating cells. Cancer Res.
67:6796–6805. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dalerba P, Dylla SJ, Park IK, Liu R, Wang
X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gupta PB, Chaffer CL and Weinberg RA:
Cancer stem cells: Mirage or reality? Nat Med. 15:1010–1012. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hirschmann-Jax C, Foster AE, Wulf GG,
Nuchtern JG, Jax TW, Gobel U, Goodell MA and Brenner MK: A distinct
'side population' of cells with high drug efflux capacity in human
tumor cells. Proc Natl Acad Sci USA. 101:14228–14233. 2004.
View Article : Google Scholar
|
|
6
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feuring-Buske M and Hogge DE: Hoechst
33342 efflux identifies a subpopulation of cytogenetically normal
CD34(+)CD38(−) progenitor cells from patients with acute myeloid
leukemia. Blood. 97:3882–3889. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wulf GG, Wang RY, Kuehnle I, Weidner D,
Marini F, Brenner MK, Andreeff M and Goodell MA: A leukemic stem
cell with intrinsic drug efflux capacity in acute myeloid leukemia.
Blood. 98:1166–1173. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: From genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee TK, Castilho A, Ma S and Ng IO: Liver
cancer stem cells: Implications for a new therapeutic target. Liver
Int. 29:955–965. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K
and Hirohashi S: Dysadherin, a cancer-associated cell membrane
glycoprotein, down-regulates E-cadherin and promotes metastasis.
Proc Natl Acad Sci USA. 99:365–370. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nam JS, Hirohashi S and Wakefield LM:
Dysadherin: A new player in cancer progression. Cancer Lett.
255:161–169. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Royds JA and Iacopetta B: p53 and disease:
When the guardian angel fails. Cell Death Differ. 13:1017–1026.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim CF, Jackson EL, Woolfenden AE,
Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT and Jacks T:
Identification of bronchioalveolar stem cells in normal lung and
lung cancer. Cell. 121:823–835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Teng Y, Wang X, Wang Y and Ma D:
Wnt/β-catenin signaling regulates cancer stem cells in lung cancer
A549 cells. Biochem Biophys Res Commun. 392:373–379. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song J, Chang I, Chen Z, Kang M and Wang
CY: Characterization of side populations in HNSCC: Highly invasive,
chemoresistant and abnormal Wnt signaling. PLoS One. 5:e114562010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bradford MM: Rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding 72. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi Y, Fu X, Hua Y, Han Y, Lu Y and Wang
J: The side population in human lung cancer cell line NCI-H460 is
enriched in stem-like cancer cells. PLoS One. 7:e333582012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F,
Maclaughlin DT and Donahoe PK: Ovarian cancer side population
defines cells with stem cell-like characteristics and Mullerian
Inhibiting Substance responsiveness. Proc Natl Acad Sci USA.
103:11154–11159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Haraguchi N, Utsunomiya T, Inoue H, Tanaka
F, Mimori K, Barnard GF and Mori M: Characterization of a side
population of cancer cells from human gastrointestinal system. Stem
Cells. 24:506–513. 2006. View Article : Google Scholar
|
|
22
|
Patrawala L, Calhoun T,
Schneider-Broussard R, Zhou J, Claypool K and Tang DG: Side
population is enriched in tumorigenic, stem-like cancer cells,
whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
Cancer Res. 65:6207–6219. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bunting KD, Zhou S, Lu T and Sorrentino
BP: Enforced P-glycoprotein pump function in murine bone marrow
cells results in expansion of side population stem cells in vitro
and repopulating cells in vivo. Blood. 96:902–909. 2000.PubMed/NCBI
|
|
24
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Norwood K, Wang RY, Hirschmann-Jax C,
Andreeff M, Brenner MK, Goodell MA and Wulf GG: An in vivo
propagated human acute myeloid leukemia expressing ABCA3. Leuk Res.
28:295–299. 2004. View Article : Google Scholar
|
|
26
|
Kawaguchi-Ihara N, Murohashi I, Nara N and
Tohda S: Promotion of the self-renewal capacity of human acute
leukemia cells by Wnt3A. Anticancer Res. 28(5A): 2701–2704.
2008.PubMed/NCBI
|
|
27
|
Khan NI, Bradstock KF and Bendall LJ:
Activation of Wnt/beta-catenin pathway mediates growth and survival
in B-cell progenitor acute lymphoblastic leukaemia. Br J Haematol.
138:338–348. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ysebaert L, Chicanne G, Demur C, De Toni
F, Prade-Houdellier N, Ruidavets JB, Mansat-De Mas V, Rigal-Huguet
F, Laurent G, Payrastre B, et al: Expression of beta-catenin by
acute myeloid leukemia cells predicts enhanced clonogenic
capacities and poor prognosis. Leukemia. 20:1211–1216. 2006.
View Article : Google Scholar : PubMed/NCBI
|
